JP2004517145A5 - - Google Patents

Download PDF

Info

Publication number
JP2004517145A5
JP2004517145A5 JP2002557935A JP2002557935A JP2004517145A5 JP 2004517145 A5 JP2004517145 A5 JP 2004517145A5 JP 2002557935 A JP2002557935 A JP 2002557935A JP 2002557935 A JP2002557935 A JP 2002557935A JP 2004517145 A5 JP2004517145 A5 JP 2004517145A5
Authority
JP
Japan
Prior art keywords
halogen
hydrogen
compounds
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2002557935A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004517145A (ja
JP4417624B2 (ja
Filing date
Publication date
Priority claimed from DE10102053A external-priority patent/DE10102053A1/de
Application filed filed Critical
Publication of JP2004517145A publication Critical patent/JP2004517145A/ja
Publication of JP2004517145A5 publication Critical patent/JP2004517145A5/ja
Application granted granted Critical
Publication of JP4417624B2 publication Critical patent/JP4417624B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2002557935A 2001-01-17 2001-12-24 ピペラジニルカルボニルキノリンおよびイソキノリン Expired - Fee Related JP4417624B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10102053A DE10102053A1 (de) 2001-01-17 2001-01-17 Piperazinylcarbonylchinoline und -isochinoline
PCT/EP2001/015311 WO2002057256A1 (en) 2001-01-17 2001-12-24 Piperazinylcarbonylquinolines and -isoquinolines

Publications (3)

Publication Number Publication Date
JP2004517145A JP2004517145A (ja) 2004-06-10
JP2004517145A5 true JP2004517145A5 (enExample) 2009-06-18
JP4417624B2 JP4417624B2 (ja) 2010-02-17

Family

ID=7670921

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002557935A Expired - Fee Related JP4417624B2 (ja) 2001-01-17 2001-12-24 ピペラジニルカルボニルキノリンおよびイソキノリン

Country Status (22)

Country Link
US (1) US7329749B2 (enExample)
EP (1) EP1366039B1 (enExample)
JP (1) JP4417624B2 (enExample)
KR (1) KR100854481B1 (enExample)
CN (1) CN1249055C (enExample)
AR (1) AR035682A1 (enExample)
AT (1) ATE304010T1 (enExample)
BR (1) BR0116774A (enExample)
CA (1) CA2434773C (enExample)
CZ (1) CZ304144B6 (enExample)
DE (2) DE10102053A1 (enExample)
DK (1) DK1366039T3 (enExample)
ES (1) ES2248230T3 (enExample)
HU (1) HU230250B1 (enExample)
MX (1) MXPA03006360A (enExample)
MY (1) MY127293A (enExample)
PL (1) PL212087B1 (enExample)
RU (1) RU2280034C2 (enExample)
SI (1) SI1366039T1 (enExample)
SK (1) SK287333B6 (enExample)
WO (1) WO2002057256A1 (enExample)
ZA (1) ZA200306331B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA03006294A (es) * 2001-01-18 2003-09-16 Merck Patent Gmbh Proteinas de fusion disfuncionales con actividad glucocerebrosidasa.
AU2003231032B2 (en) * 2002-04-22 2008-07-10 Johns Hopkins University School Of Medicine Modulators of hedgehog signaling pathways, compositions and uses related thereto
HRP20050092A2 (en) * 2002-06-29 2005-02-28 Zentaris Gmbh Arylcarbonylpiperazines and heteroarylcarbonylpiperazines and the use thereof for treating benign and malignant tumour diseases
WO2006010515A2 (en) * 2004-07-29 2006-02-02 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with 5-hydroxytryptamine 2a receptor (5ht2a)
JP5916730B2 (ja) * 2010-09-06 2016-05-11 グアンジョウ インスティテュート オブ バイオメディスン アンド ヘルス,チャイニーズ アカデミー オブ サイエンスィズ アミド化合物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5093341A (en) * 1987-12-17 1992-03-03 Merrell Dow Pharmaceuticals Inc. N-aralkyl piperidine derivatives useful as antithrombolytic agents
US4970714A (en) * 1989-01-05 1990-11-13 International Business Machines Corp. Adaptive data link protocol
EP0957100B1 (en) 1997-07-07 2004-10-27 Kowa Co., Ltd. Diamine derivatives and pharmaceutical containing the same
AU772477B2 (en) * 1998-08-28 2004-04-29 Scios Inc. Inhibitors of p38-alpha kinase
DE19934433A1 (de) * 1999-07-22 2001-01-25 Merck Patent Gmbh N-(Indolcarbonyl-)piperazinderivate

Similar Documents

Publication Publication Date Title
JP2004538039A5 (enExample)
JP2002532112A5 (enExample)
JP2003514758A5 (enExample)
JP2003520232A5 (enExample)
ATE539062T1 (de) Bizyklishe verbindung, ihre herstellung und verwendung
ATE270817T1 (de) Fungizide
JP2005510235A5 (enExample)
JP2003520017A5 (enExample)
MXPA03007142A (es) Derivados de carbolina.
JP2006506499A5 (enExample)
JP2003526626A5 (enExample)
DE60205888D1 (de) Das citrat-salz des 5,8,14,-triazatetracyclo(10.3.1.02,11.04,9)-hexadeca-2(11),3,5,7,9-pentaens
JP2003515534A5 (enExample)
NO20041200L (no) Fremgangsmate for fremstilling av citalopram.
JP2008501649A5 (enExample)
ATE311389T1 (de) Wirkstoffvorläufer von imidazopyridin-derivaten
JP2004035399A5 (enExample)
JP2005528357A5 (enExample)
JP2006505391A5 (enExample)
NO20031414D0 (no) Ny oksabispidinforbindelse som er nyttig i behandlingen av hjertearrytmier
JP2001354766A5 (enExample)
PT1204659E (pt) Benzofuranos serotoninergicos
JP2005536763A5 (enExample)
NO20000456L (no) FremgangsmÕte for fremstilling av 1,2-dikloretan
CA2445620A1 (en) Tetracyclic compounds as pde5-inhibitors